全文获取类型
收费全文 | 5212篇 |
免费 | 374篇 |
国内免费 | 121篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 165篇 |
妇产科学 | 85篇 |
基础医学 | 626篇 |
口腔科学 | 169篇 |
临床医学 | 536篇 |
内科学 | 1167篇 |
皮肤病学 | 83篇 |
神经病学 | 278篇 |
特种医学 | 220篇 |
外科学 | 778篇 |
综合类 | 311篇 |
一般理论 | 5篇 |
预防医学 | 410篇 |
眼科学 | 158篇 |
药学 | 367篇 |
中国医学 | 9篇 |
肿瘤学 | 313篇 |
出版年
2023年 | 46篇 |
2022年 | 95篇 |
2021年 | 176篇 |
2020年 | 111篇 |
2019年 | 137篇 |
2018年 | 136篇 |
2017年 | 115篇 |
2016年 | 125篇 |
2015年 | 118篇 |
2014年 | 152篇 |
2013年 | 196篇 |
2012年 | 317篇 |
2011年 | 289篇 |
2010年 | 179篇 |
2009年 | 179篇 |
2008年 | 224篇 |
2007年 | 289篇 |
2006年 | 237篇 |
2005年 | 241篇 |
2004年 | 186篇 |
2003年 | 188篇 |
2002年 | 170篇 |
2001年 | 151篇 |
2000年 | 156篇 |
1999年 | 131篇 |
1998年 | 104篇 |
1997年 | 79篇 |
1996年 | 61篇 |
1995年 | 71篇 |
1994年 | 55篇 |
1993年 | 61篇 |
1992年 | 61篇 |
1991年 | 66篇 |
1990年 | 81篇 |
1989年 | 86篇 |
1988年 | 68篇 |
1987年 | 64篇 |
1986年 | 60篇 |
1985年 | 50篇 |
1984年 | 38篇 |
1983年 | 28篇 |
1982年 | 39篇 |
1981年 | 31篇 |
1980年 | 36篇 |
1979年 | 32篇 |
1978年 | 26篇 |
1977年 | 30篇 |
1976年 | 23篇 |
1975年 | 21篇 |
1973年 | 19篇 |
排序方式: 共有5707条查询结果,搜索用时 15 毫秒
41.
There has been no report of byssinosis in Hong Kong although the textile industry has been one of the leading industries for many years. Three workers with a long history of exposure to cotton dust had chronic obstructive airways disease precipitated by their work environment. One had irreversible airways obstruction but none had chronic bronchitis, emphysema, or asthma. Only one gave a history of "Monday morning tightness," and this was attributed to the fact that most of the textile workers in Hong Kong work seven days a week. It was suggested that a survey be carried out to ascertain the importance of byssinosis in the textile workers of Hong Kong and tha byssinosis should there be added to the list of notifiable occupational diseases. 相似文献
42.
Sylvie Perreault Huy Ong Patrick du Souich 《Journal of pharmacokinetics and pharmacodynamics》1992,20(5):461-476
This study assessed the influence of dose and route of administration on salbutamol kinetics and hypokaliemic effect. Salbutamol plasma kinetics were studied in a first group of 6 rabbits who received 60, 800, and 60 g/kg by the intravenous (iv), oral (po), and intratracheal (it) routes, respectively, at 1-week intervals. A second group of 6 rabbits received 120, 2400, and 120 g/kg of salbutamol by the same three routes. Multiple blood samples were withdrawn to assay salbutamol and potassium. Following iv salbutamol (60 g/kg), total plasma clearance was 82±5 ml/min per kg, apparent volume of distribution was 5.0±0.5 l/kg, and terminal half- life was 41±2 min. Similar values were estimated when 120 g/kg of salbutamol was administered iv or was given po or it. The bioavailability of po and it salbutamol was approximately 1 and 20%, respectively. For the first group, the maximal decrease in plasma potassium elicited by salbutamol was 0.80±0.19, 0.48±0.22, and 0.78±0.46 mmol/l, and for the second group, maximal decrement was 1.31±0.37, 0.70±0.24, and 0.84±0.17 mmol/l for the iv, po, and it routes, respectively. Compared to salbutamol peak plasma concentrations, maximal decrease in plasma potassium appeared between 60 and 108 min later for the iv route, 90 and 25 min later for po and it routes, and for this reason, the hypokaliemic effect was not associated to salbutamol plasma concentrations. The hypokaliemic effect was dependent upon the route, e.g., po>it>iv. It is concluded that (i) salbutamol plasma kinetics are first-order independently of the route of administration, and (ii) salbutamol hypokaliemic effect is modulated by the dose and the route of administration.List of abbreviations
AUC
Area under salbutamol plasma concentration-time curve
- clINT
Salbutamol intrinsic clearance
- clT
Salbutamol total plasma clearance
- cMAX
Salbutamol maximal plasma concentration
-
F
Fraction of the dose of salbutamol reaching the systemic circulation
- iv
Intravenous route of administration
- it
Intratracheal route of administration
- po
Oral route of administration
- Varea
Salbutamol apparent volume of distribution
- T
2
1
Salbutamol half-life of the terminal phase
- tMAX
Time to observe the maximal decrease in plasma potassium
- eMAX
Predicted maximal effect of salbutamol
- EC50
Concentration of salbutamol eliciting 50% of eMAX
Supported by the Medical Research Council of Canada (MT-10874). Sylvie Perreault is recipient of a Bourse Formation de troisième cycle des Fonds de la Recherche en Santé du Québec. 相似文献
43.
T. S. Ong 《Documenta ophthalmologica. Advances in ophthalmology》1982,52(2):355-361
This Capsular Lens (ONG, type IV, to be called O.C.L.) has been developed for routinely performed extracapsular cataract extraction with lens implantation. The fundamental surgical procedure was based on continuing experience with the bimanual aspiration-irrigation technique and system developed by the author in 1971. The biomechanical properties of the asymmetric partly flexible, haptic loops are designed to give tensionfree fixation in two capsular pockets. The plano-anterior position of the lens ensures well-defined irido-lenticular clearance and proper alignment of the convex side with the posterior capsule. Consequently no iridectomy or iridotomy is needed for proper aqueous flow. 相似文献
44.
Most children with benign childhood epilepsy with centrotemporal spikes have few seizures, and some have only one. We describe two children with interictal and ictal findings consistent with this epileptic syndrome but with severe intractable seizures and cognitive decline that resulted in consideration for epilepsy surgery. Spontaneous remission occured in one child; the other is still young. Despite the high seizure burden and cognitive decline, surgical consideration should be withheld, as these seizures are likely to remit. 相似文献
45.
Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare but distinct clinicopathologic entity characterised histologically by a benign s histiocytic proliferation. Isolated involvement of extranodal sites without concomitant nodal disease is rare. We describe the pathological features of 2 cases of Rosai-Dorfman disease that were clinically confined to the skin. In both male adult Chinese patients, proliferation of histiocytes was accompanied by S-100 protein expression demonstrated immunohistochemically within the histiocytes. The pathology of Rosai-Dorfman disease and its microscopic differential diagnoses are discussed. 相似文献
46.
47.
We report an unusual case of focal nodular hyperplasia (FNH) occurring in a 19-month-old female without a typical central fibrous scar. Ultrasound demonstrated a solid, hypoechoic, highly vascular mass situated in the left lobe of the liver. Computed tomography showed a solid mass with no evidence of a central fibrous scar. A hepatic angiogram demonstrated enlarged right and left hepatic arteries supplying the vascular tumour, with early venous drainage into the inferior vena cava; a feature which has not been previously described. Surgical resection was carried out and a solid, nodular tumour measuring 9 x 4 x 4 cm was removed. The diagnosis of FNH was made histologically. The characteristic imaging findings of FNH will be discussed and a review of the literature of FNH in children will be presented. 相似文献
48.
Wang WS; Hsieh RK; Chiou TJ; Liu JH; Fan FS; Yen CC; Tung SL; Chen PM 《Japanese journal of clinical oncology》1998,28(9):551-554
A 54-year-old man was treated with weekly 24-h infusion of high-dose
5-fluorouracil (2600 mg/m2) and leucovorin (100 mg/m2) for metastatic colon
cancer. At first, he tolerated the treatment well and no significant
toxicity was identified. After a total of eight courses of treatment, a
stable disease was observed, but mild shortness of breath was found on
occasion. The patient had no previous history of cardiac disease and the
heart performance assessed by left ventricular ejection fraction before
treatment was normal. Unfortunately, acute pulmonary edema with lethal
cardiogenic shock occurred during the ninth course of treatment, in spite
of intensive medical treatment. The chest X-ray showed extreme
cardiomegaly. Repeated assessment of his heart function by echocardiogram
and ventricular ejection fraction revealed a very poor cardiac performance.
Toxic cardiogenic shock during weekly 24-h infusion of high-dose
5-fluorouracil and leucovorin is extremely rare. To the best of our
knowledge, no case has been reported in the English literature. We report a
case and the relevant literature about the incidence, clinical picture and
possible pathophysiology on 5-fluorouracil-related cardioxicity is
reviewed.
相似文献
49.
Delay times and management of acute myocardial infarction in indigenous and non-indigenous people in the Northern Territory 总被引:2,自引:0,他引:2
OBJECTIVES: To investigate differences in presentation and management of Indigenous and non-Indigenous patients hospitalised with acute myocardial infarction (AMI). DESIGN: Retrospective review of hospital medical records. PARTICIPANTS AND SETTING: 122 patients with definite or possible AMI admitted to hospitals in the Top End of the Northern Territory (NT) in 1996. MAIN OUTCOME MEASURES: Percentage receiving thrombolytic therapy; delays from symptom onset to primary and emergency department presentations, first and diagnostic electrocardiograms, thrombolytic therapy and aspirin; drugs prescribed during hospitalisation. RESULTS: Thrombolytic therapy was given to 12/41 Indigenous patients (29%) and 38/81 non-Indigenous patients (47%) (P = 0.06). Presentation delay over 12 hours was the reason for not giving thrombolytic therapy for 14/29 Indigenous patients (48%) and 8/43 non-Indigenous patients (19%) (P < 0.01). Median delay times were longer for Indigenous patients for all six categories of delay, although the difference was significant only for delay to emergency department presentation (10:00 versus 3:26 hours; P < 0.01) and to diagnostic electrocardiogram (8:10 versus 3:50 hours; P < 0.01). Delays were also longer for patients from rural compared with urban areas. Once diagnosed, Indigenous patients were as likely as non-Indigenous patients to receive aspirin (93% versus 96%) and beta-blockers (70% versus 69%) and more likely to receive angiotensin-converting enzyme inhibitors (60% versus 40%; P = 0.03). CONCLUSIONS: Delays in presentation affect Indigenous people living in rural and urban areas as well as non-Indigenous people living in rural areas. Concerted efforts are needed to improve health service access in rural areas and to encourage Indigenous people with persistent chest pain to present earlier. 相似文献
50.
A randomised, prospective trial was conducted to assess the efficacy of various means of alleviating the pain of subcutaneous lidocaine infiltration. One hundred and twenty-two patients were randomly allocated to different groups to receive buffered lidocaine 1%, warmed lidocaine 1% or infiltration by the counter-irritation technique. A visual analogue pain score was recorded at different stages of cannulation and results showed that pain scores were significantly lower in the group receiving buffered lidocaine 1% (p < 0.02) and in the counter-irritation group (p < 0.05). Thus buffering lidocaine 1% and administration of lidocaine 1% by the counter-irritation technique is effective in relieving the pain of lidocaine infiltration. 相似文献